Evolent Health Inc (EVH, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Evolent Health Inc is engaged in healthcare delivery and payment. It markets and sells its services to providers throughout the United States. Evolent Health Inc has a market cap of $760.740 million; its shares were traded at around $8.98 with and P/S ratio of 0.88.
For the last quarter Evolent Health Inc reported a revenue of $236.5 million, compared with the revenue of $193.1 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $846.4 million, an increase of 35% from last year. For the complete 30-year financial data, please go here.. For the last five years Evolent Health Inc had an average revenue decline of 0% a year.
The reported loss per diluted share was $3.67 for the year, compared with the loss per share of $3.55 in the previous year. The Evolent Health Inc had an operating margin of -14.23%, compared with the operating margin of -8.23% a year before. The 10-year historical median operating margin of Evolent Health Inc is -23.85%. The profitability rank of the company is 2 (out of 10).
At the end of the fiscal year, Evolent Health Inc has the cash and cash equivalents of $101.0 million, compared with $228.3 million in the previous year. The company had no long term debt, compared with $221.0 million in the previous year. Evolent Health Inc has a financial strength rank of 6 (out of 10).
At the current stock price of $8.98, Evolent Health Inc is traded at 63.4% discount to its historical median P/S valuation band of $24.55. The P/S ratio of the stock is 0.88, while the historical median P/S ratio is 3.24. The stock lost 29.95% during the past 12 months.
For the complete 20-year historical financial data of EVH, click here.
